The Top Line

The Top Line offers PR-friendly access to senior pharma/biotech leaders and market-heavy topics. Booking guests delivers credibility and industry visibility for healthcare brands, with discussable angles on FDA outcomes, AI governance, and drug development trends.

100 episodes, Weekly, 4.1 rating

<1k, Male, USA

Fraiser Kansteiner

Business News, News, Business, Health & Fitness, Medicine, Science, Technology

MD, DO, PhD, or senior life-sciences executive (CEO/CSO/CMO/VP)

FDA approvals or pivotal research breakthroughs, leadership roles in pharma/biotech, speaking engagements at major conferences, public thought leadership in life sciences

Brian Hilberdink - BI US Market Strategy, FDA Approvals For Idiopathic Pulmonary Fibrosis And Lung Cancer, BI US Commercialization Push, Marie Flanagan - AI Governance In Healthcare, Safety And Accountability, Human Oversight, Transparency, Ben Adams - Week's Headlines, Pharma Policy Updates, Market Dynamics, Freda Lewis-Hall - Trust In Pharma, Patient Engagement, AI And Omnichannel Outreach, Robert Abel - Ai-driven Drug Discovery, Computational Drug Discovery, Protein Structure Prediction

pharma, biotech, drug development, FDA approvals, gene therapy, hemophilia, AI in healthcare, drug safety, regulatory affairs, commercialization